|
1 Grow DR, Williams RF, Hsiu JG, et al. Antiprogestin and/or gonadotropin－releasing hormone agonist for endometriosis treatment and bone maintenance: A 1－year primate study. J Clin Endocrinol Metab, 1996, 81(5)：1933－1939.
|
|
2 Kettel LM，Murphy AA，Morales AJ, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril, 1996, 65(1)：23－28.
|
|
3 Chwalisz K, Mattia－Goldberg C, Lee M, et al. Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil. Fertil Steril, 2004, 82(suppl 2): S83－84.
|
|
4 Harris HA, Bruner－Tran KL, Zhang X, et al. A selective estrogen receptor－beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod, 2005, 20(4): 936－941.
|
|
5 Swisher DK, Tague RM, Seyler DE. Effects of the selective estrogen receptor modulator raloxifene on explanted uterine growth in rats. Drug Devel Res, 1995, 36：43－45.
|
|
6 Fanning PM, Kuehl TJ, Lee R, et al. Video mapping to assess efficacy of an antiestrogen (raloxifene) on spontaneous endometriosis in the rbesus monkey, Macaca mulata. In: Kuehl TJ, ed, Bunkey Day Proceeding, 1996：51－61.
|
|
7 Jones RC. The effect of a luteinizing hormone－releasing hormone antagonist on experimental endometriosis in the rat. Acta Endocrinol (Copenh), 1987, 114(3)：379－382.
|
|
8 Noble LS, Simpson ER, Johns A, et al. Aromatase expression in endometriosis. J Clin Endocrinol Metab，1996, 81(1)：174－179.
|
|
9 Yano S, Ikegami Y, Nakao K. Studies on the effect of the new non－steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats. Arzneimittelforschung, 1996, 46(2)：192－195.
|
|
10 Fang Z, Yang S, Gurates B, et al. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab, 2002, 87(7): 3460－3466.
|
|
11 Takayama K, Zeitoun K, Gunby RT, et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril, 1998, 69：709－713.
|
|
12 Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: A pilot study. Fertil Steril, 2004, 81(2)：290－296.
|
|
13 Shippen ER, West WJ Jr. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril, 2004, 81(5)：1395－1398.
|
|
14 Soysal S, Soysal ME, Ozer S, et al. The effects of post－surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: A prospective randomized trial. Hum Reprod, 2004, 19(1)：160－167.
|
|
15 Golan A, Dargenio R, Winston RM. The effect of treatment on experimentally produced endometrial peritoneal implants. Fertil Steril, 1986, 46(5)：954－958.
|
|
16 Dargenio R, Corbucci MG, Lamanna MA, et al. Indomethacin and fertility in experimental endometriosis. Acta Eur Fertil，1992, 23(2)：85－88.
|
|
17 Matsuzaki S, Canis M, Darcha C, et al. Cyclooxygenase－2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril, 2004，82(6)：1609－1615.
|
|
18 Dogan E, Saygili U, Posaci C, et al. Regression of endometrial explants in rats treated with the cyclooxygenase－2 inhibitor rofecoxib. Fertil Steril, 2004, 82(suppl 3)：1115－1120.
|
|
19 Efstathiou JA, Sampson DA, Levine Z, et al. Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. Fertil Steril, 2005, 83(1)：171－181.
|
|
20 Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immunol, 1994, 31(2－3)：151－162.
|
|
21 Balasch J, Creus M, Fabregues F, et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: A pilot randomized clinical trial. Hum Reprod, 1997, 12(9)：2046－2050.
|
|
22 Keenan JA, Williams－Boyce PK, Massey PJ, et al. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril, 1999, 72(1)：135－141.
|
|
23 Ingelmo JM, Quereda F, Acien P. Intraperitoneal and subcutaneous treatment of experimental endometriosis with recombinant human interferon－alpha－2b in a murine model. Fertil Steril, 1999, 71(5)：907－911.
|
|
24 Mohamed Ali AF, Fateen B, Ezzet A, et al. Laparoscopic intraperitoneal injection of human interferon－2b in the treatment of pelvic endometriosis: A new modality. Obstet Gynecol, 2000, 95(suppl 1): S47－S48.
|
|
25 Acien P, Quereda F, Campos A, et al. Use of intraperitoneal interferon alpha－2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin－releasing hormone analog: A randomized clinical trial. Fertil Steril, 2002, 78(4): 705－711.
|
|
26 D'Antonio M, Martelli F, Peano S, et al. Ability of recombinant human TNF binding protein－1 (r－hTBP－1) to inhibit the development of experimentally－induced endometriosis in rats. J Reprod Immunol, 2000, 48(2)：81－98.
|
|
27 D'Hooghe TM, Cuneo S, Nugent N, et al. Recombinant human TNF binding protein－1 (r－hTBP－1) inhibits the development of endometriosis in baboons: A prospective, randomized, placebo－ and drug－controlled study. Fertil Steril, 2001, 76(suppl 1): S1.
|
|
28 Falconer H, Mwenda JM, Chai DC, et al. Treatment with anti－TNF antibody c5N reduces the extent of induced endometriosis in the baboon. Fertil Steril, 2004, 82(suppl 2): S54－S55.
|
|
29 Braun DP, Ding J, Dmowski WP. Peritoneal fluid－mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor－alpha in women with endometriosis. Fertil Steril, 2002, 78(4)：727－732.
|
|
30 Somigliana E, Vigano P, Rossi G, et al. Endometrial ability to implant in ectopic sites can be prevented by interleukin－12 in a murine model of endometriosis. Hum Reprod, 1999, 14(12)：2944－2950.
|
|
31 Levine Z, Efstathiou JA, Sampson DA, et al. Angiogenesis inhibitors suppress endometriosis in a murine model. J Soc Gynecol Investig, 2002, 9(suppl 1): 264.
|
|
32 Hull ML, Charnock－Jones DS, Chan CL, et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab, 2003, 88(6)：2889－2899.
|
|
33 Nap AW, Griffioen AW, Dunselman GA, et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab, 2004, 89(3)：1089－1095.
|
|
34 Park A, Chang P, Ferin M, et al. Inhibition of endometriosis development in Rhesus monkeys by blocking VEGF receptor：A novel treatment for endometriosis. Fertil Steril, 2004, 82(suppl 2): S71.
|
|
35 Mori T, Yamasaki S, Masui F, et al. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO－4817, in mice. Exp Biol Med, 2001, 226：429－433.
|